eural adaptations to vitamin D supplementation in older adults: A pilot study
- Conditions
- FallsSarcopeniaVitamin D deficiencyNeurological - Studies of the normal brain and nervous systemMusculoskeletal - Other muscular and skeletal disordersDiet and Nutrition - Other diet and nutrition disorders
- Registration Number
- ACTRN12612000592842
- Lead Sponsor
- Deakin University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 30
Healthy older women (aged 60 years and over) with insufficient serum vitamin D levels (25-hydroxyvitamin D between 25 and 60 nmol/L) who are able to speak English proficiently and walk unaided or with minimal assistance (walking stick) for at least 50 m.
Participants will be ineligible based on the following: 1) current or prior participation in resistance exercise (greater or equal to once a week) and/or participating in greater than 150 min of physical activity per week in the past 3 months, 2) acute or terminal illness likely to compromise exercise testing, 3) unstable or ongoing cardiovascular/ respiratory disorders, 4) musculoskeletal or neurological diseases disrupting voluntary movement or that might limit testing, 5) upper or lower extremity fracture in the past 3 months, 6) visual impairment not corrected with glasses; 7) unable to follow instructions; and 8) currently taking vitamin D supplements (greater than 200 IU/d), and 9) not willing to take vitamin D supplements or placebo supplements for 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eural excitability and inhibition measured by Transcranial Magnetic Stimulation (TMS)[Meausrements will be made at baseline and 3 months];Muscle function (number of chair-rises within 30 s; 3-metre timed-up-and-go test, the four-square test, where subjects must step around four squares in one direction and back again)[Meausrements will be made at baseline and 3 months]
- Secondary Outcome Measures
Name Time Method Maximal muscle force (strength) and power for the muscles of the legs (Biodex machine)[Meausrements will be made at baseline and 3 months];Serum 25-hydroxyvitamin D[Meausrements will be made at baseline and 3 months];Health-related quality of life assessed by the SF-36 questionnaire[Meausrements will be made at baseline and 3 months];Cognitive function (mini-mental state examination)[Meausrements will be made at baseline and 3 months]